DNA-based delivery of G-CSF as a durable and efficacious approach to treat severe chronic neutropenia.
- DOI
- 10.1016/j.ymthe.2025.03.038
- Published
- 2025 Jul 2
- Container
- Molecular therapy : the journal of the American Society of Gene Therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymthe.2025.03.038,
title = {DNA-based delivery of G-CSF as a durable and efficacious approach to treat severe chronic neutropenia.},
author = {Drozdz MM and Thompson AT and Sasset L and Cameron AD and Yao X and Maji D and Campbell DA and Sussman C and Miller R and Liberatore RA},
year = {2025},
journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
doi = {10.1016/j.ymthe.2025.03.038},
url = {https://doi.org/10.1016/j.ymthe.2025.03.038}
}RIS
TY - JOUR TI - DNA-based delivery of G-CSF as a durable and efficacious approach to treat severe chronic neutropenia. AU - Drozdz MM AU - Thompson AT AU - Sasset L AU - Cameron AD AU - Yao X AU - Maji D AU - Campbell DA AU - Sussman C AU - Miller R AU - Liberatore RA PY - 2025 JO - Molecular therapy : the journal of the American Society of Gene Therapy DO - 10.1016/j.ymthe.2025.03.038 UR - https://doi.org/10.1016/j.ymthe.2025.03.038 ER -
APA
MM, D., AT, T., L, S., AD, C., X, Y., D, M., DA, C., C, S., R, M., & RA, L. (2025). DNA-based delivery of G-CSF as a durable and efficacious approach to treat severe chronic neutropenia.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2025.03.038
Source records
- pubmed · retrieved 2026-09-26T21:01:37.724Z